↓ Skip to main content

Dove Medical Press

Dietary Supplement of Anoectochilus roxburghii (Wall.) Lindl. Polysaccharides Ameliorates Cognitive Dysfunction Induced by High Fat Diet via “Gut-Brain” Axis

Overview of attention for article published in Drug Design, Development and Therapy, June 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
11 Mendeley
Title
Dietary Supplement of Anoectochilus roxburghii (Wall.) Lindl. Polysaccharides Ameliorates Cognitive Dysfunction Induced by High Fat Diet via “Gut-Brain” Axis
Published in
Drug Design, Development and Therapy, June 2022
DOI 10.2147/dddt.s356934
Pubmed ID
Authors

Liya Fu, Wanlong Zhu, Dongmei Tian, Yong Tang, Yun Ye, Qiming Wei, Chengbin Zhang, Wenqiao Qiu, Dalian Qin, Xuping Yang, Yilan Huang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 18%
Professor > Associate Professor 1 9%
Student > Doctoral Student 1 9%
Student > Ph. D. Student 1 9%
Student > Master 1 9%
Other 1 9%
Unknown 4 36%
Readers by discipline Count As %
Neuroscience 2 18%
Environmental Science 1 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Agricultural and Biological Sciences 1 9%
Medicine and Dentistry 1 9%
Other 0 0%
Unknown 5 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2022.
All research outputs
#19,961,193
of 25,392,582 outputs
Outputs from Drug Design, Development and Therapy
#1,313
of 2,270 outputs
Outputs of similar age
#315,974
of 446,492 outputs
Outputs of similar age from Drug Design, Development and Therapy
#17
of 42 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,270 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,492 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.